phosphorylcholine and piperidines

phosphorylcholine has been researched along with piperidines in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (44.44)	18.2507
2000's	1 (11.11)	29.6817
2010's	2 (22.22)	24.3611
2020's	2 (22.22)	2.80

Authors

Authors	Studies
Engel, J; Hilgard, P; Kutscher, B; Maurer, HR; Nössner, G; Schumacher, W; Stekar, J; Voegeli, R	1
Collier, B; Tandon, A	1
Berger, MR; Brun, R; Kaminsky, R; Konstantinov, SM; Zillmann, U	1
Grosman, N	1
Allessie, MA; Brandts, B; Trappe, HJ; Tüttelmann, F; Van Bracht, M	1
Orlowski, RZ	1
Bjune, K; Naderi, S; Wierød, L	1
Adamson, PJ; Badenoch, PR; Brennan, C; Gordon, DL; Marshman, G; Tam, PCK; Teh, JSK	1
Abourehab, MAS; Amagase, K; Bekhit, AA; Bekhit, SA; El-Saghier, AMM; Ibrahim, TM; Kadry, AM; Mohamed, MAA	1

Reviews

1 review(s) available for phosphorylcholine and piperidines

Article	Year
Novel agents for multiple myeloma to overcome resistance in phase III clinical trials. Seminars in oncology, 2013, Volume: 40, Issue:5 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunologic Factors; Indoles; Multiple Myeloma; Oligopeptides; Panobinostat; Phosphorylcholine; Piperidines; Proteasome Inhibitors; Pyridines; Remission Induction; Thalidomide; Thiazoles; Treatment Outcome; Vorinostat	2013

Article

Year

Novel agents for multiple myeloma to overcome resistance in phase III clinical trials.

Seminars in oncology, 2013, Volume: 40, Issue:5

Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Clinical Trials, Phase III as Topic; Disease-Free Survival; Drug Resistance, Neoplasm; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Immunologic Factors; Indoles; Multiple Myeloma; Oligopeptides; Panobinostat; Phosphorylcholine; Piperidines; Proteasome Inhibitors; Pyridines; Remission Induction; Thalidomide; Thiazoles; Treatment Outcome; Vorinostat

2013

Other Studies

8 other study(ies) available for phosphorylcholine and piperidines

Article	Year
Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133. Cancer chemotherapy and pharmacology, 1993, Volume: 32, Issue:6 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Cell Differentiation; Female; Ferrets; Mammary Neoplasms, Experimental; Phosphorylcholine; Piperidines; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Vomiting	1993
Increased acetylcholine content induced by adenosine in a sympathetic ganglion and its subsequent mobilization by electrical stimulation. Journal of neurochemistry, 1993, Volume: 60, Issue:6 Topics: Acetylcholine; Adenine Nucleotides; Adenosine; Adenosine Triphosphate; Animals; Cats; Dose-Response Relationship, Drug; Electric Stimulation; Female; Ganglia, Sympathetic; Kinetics; Male; Neuromuscular Depolarizing Agents; Perfusion; Phospholipids; Phosphorylcholine; Piperidines	1993
Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. Acta tropica, 1997, Apr-15, Volume: 64, Issue:3-4 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Drug Synergism; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Molecular Structure; Phenylbutazone; Phosphorylcholine; Piperidines; Platelet Activating Factor; Specific Pathogen-Free Organisms; Trypanosoma brucei brucei; Trypanosomiasis, African	1997
Effect of the anti-neoplastic agents edelfosine (ET-18-OCH3), ilmofosine (BM 41.440) and the hexadecylphosphocholine analogues D-20133 and D-21266 on histamine release from isolated rat mast cells. Immunopharmacology, 1999, Volume: 44, Issue:3 Topics: Animals; Antineoplastic Agents; Calcimycin; Histamine Release; Ionophores; Male; Mast Cells; Phorbol Esters; Phospholipid Ethers; Phosphorylcholine; Piperidines; Rats; Rats, Wistar	1999
Inhibition of muscarinic potassium current by the class III antiarrhythmic drug RP58866 in guinea-pig atrial myocytes. Pacing and clinical electrophysiology : PACE, 2000, Volume: 23, Issue:11 Pt 2 Topics: Acetylcholine; Adenosine; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Chromans; Guanosine 5'-O-(3-Thiotriphosphate); Guinea Pigs; Heart Atria; In Vitro Techniques; Membrane Potentials; Muscarinic Antagonists; Myocardium; Patch-Clamp Techniques; Phosphorylcholine; Piperidines; Potassium; Receptor, Muscarinic M2; Receptors, Muscarinic; Sphingosine	2000
Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms. PloS one, 2019, Volume: 14, Issue:6 Topics: Aminopyridines; Animals; Benzimidazoles; CHO Cells; Cricetinae; Cricetulus; Hep G2 Cells; Heterocyclic Compounds, 3-Ring; Humans; Imidazoles; Phosphorylcholine; Piperidines; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrazoles; Pyrimidines; Pyrroles; Quinoxalines; Receptors, LDL; Ribonucleosides; RNA Stability; RNA, Messenger; Transcriptional Activation	2019
Successful treatment of cutaneous Acanthamoeba castellanii infection with miltefosine in a patient with chronic lymphocytic leukaemia on ibrutinib. The Journal of antimicrobial chemotherapy, 2022, 02-02, Volume: 77, Issue:2 Topics: Acanthamoeba castellanii; Adenine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylcholine; Piperidines	2022
Spiro heterocycles bearing piperidine moiety as potential scaffold for antileishmanial activity: synthesis, biological evaluation, and Journal of enzyme inhibition and medicinal chemistry, 2023, Volume: 38, Issue:1 Topics: Animals; Antiprotozoal Agents; Chlorocebus aethiops; Phosphorylcholine; Piperidines; Vero Cells	2023